Shortening of Platelet Survival by Induced Hypercholesterolaemia In Rabbits and Its Prolongation by Anagrelide

Summary

Induction of atherosclerosis in rabbits by feeding a cholesterol enriched diet reduced the platelet half-life in male rabbits from 37.0 ± 4.1 hr to 30.1 ± 3.9 hr (mean ± S.D. p ≤0.01). Platelets from these animals exhibited increased sensitivity to arachidonic acid but decreased sensitivity to ADP. No significant change was found in aggregation to collagen or thrombin, or in the production of thomboxane B₂ induced by collagen.

The reduced platelet survival was dependent upon the recipient animal and not the platelet donor. Platelets from cholesterol- fed animals survived normally in normal animals, whereas platelets from normal animals in cholesterol-fed animals had a reduced platelet survival even compared to platelets from cholesterol-fed animals. This might suggest that some functional change had occurred in the cholesterol platelet in response to its altered environment.

Anagrelide (1 mg/kg/day) normalised shortened platelet survival in both male and female rabbits fed the high cholesterol diet.

Keywords

Heparin - Other mucopolysaccharides - Anticoagulation - Mode of action

• References

• 1 Anitschkow N, Chalatow S. Über experimentelle Cholesterinsteatose und ihre Bedeutung für die Entstehung einiger pathologischer Pro-zesse. Zentrabi Allg pathol 1913; 24: 1-9
• 2 Harker AL, Ross R, Glomset J. Role of the platelets in atherogenesis. Ann N Y Acad Sei 1976; 275: 321-330
• 3 Fuster V, Bowie EJ W. The von Willebrand pig as a model for atherosclerosis research. Thromb Haemostas 1978; 39: 322-332
• 4 Zmuda A, Dembinska-Kiec A, Chytokowski A, Gryglewski RJ. Experimental atherosclerosis in rabbits - platelet aggregation, throm-boxane A₂ generation and anti-aggregatory potency of prostacyclin. Prostaglandins 1977; 14: 1035-1042
• 5 Mustard JF, Packham MA. Platelets, thrombosis and drugs. Drugs 1975; 9: 19-76
• 6 Butler KD, Pay GF, Roberts JM. The effect of sulphinpyrazone and other drugs on the platelet response during the acute phase of the active Arthus reaction in guinea pigs. Thromb Res 1979; 15: 319-340
• 7 Butler KD, Wallis RB, White AM. A study of the relationship between ex vivo and in vivo effects of sulphinpyrazone in the guinea pig. Haemostasis 1979; 8: 353-360
• 8 Butler KD, Maguire ED, Smith JR, Turnbull AA, Wallis RB, White AM. Prolongation of rat tail bleeding time caused by oral doses of a thromboxane synthetase inhibitor which have little effect on platelet aggregation. Thromb Haemostas 1982; 47: 46-49
• 9 Ross R, Harker L. Hyperlipidemia and atherosclerosis. Science 1976; 193: 1094-1100
• 10 Kawaguchi H, Ishibashi T, Imai Y. Thromboxane B₂ biosynthesis and phospholipids hydrolysis in platelets from hypercholesterolemic rabbits. Lipids 1981; 16: 37-42
• 11 Stuart MJ, Gerrard JM, White JG. Effect of cholesterol on production of thromboxane B₂ by platelets in vitro. N Eng J Med 1980; 302: 6-10
• 12 Tremoli E, Ghiselli G, Maderna P, Colli S, Sirtoli CR. Metformin reduces platelet hypersensitivity in hypercholesterolemic rabbits. Atherosclerosis 1982; 41: 53-60
• 13 Dembinska-Kiec A, Rucker W, Schönhöfer PS. Effects of dipyridamole on experimental atherosclerosis. Atherosclerosis 1979; 33: 315-327
• 14 Berlin E, Matusik EJ, Young C. Effect of dietary fat on the fluidity of platelets membranes. Lipids 1980; 15: 604-608
• 15 Fleming JS, Buyniski JP. A potent new inhibitor of platelet aggregation and experimental thrombosis, anagrelide (BL-4162A). Thromb Res 1979; 15: 373-378